Asia Spot Naphtha trade-CNOOC, Asahi Kasei Mitsubishi buy Feb, March naphtha
NEW DELHI, Dec 23 (Reuters) - (For a list of market-on-close oil product
trades click [O/AS)
COUNTRY SPEC VOL DATES BUYER PRICE (Payment
period)
Dec 21
China min 70% 50-80KT Feb or March CNOOC $3 disc (60
unconfirmed days)
Japan Light 25KT H1 March Asahi Kasei low single
naphtha Mitsubishi prem
Chemical
Ethylene
South Korea hfrn 25KT H1 Feb SK Energy NA
Dec 20 2022
South Korea Light 25KT H1 Feb LG Chem +$3 prem (30
naphtha days)
South Korea hfrn 25KT H1 Feb GS Caltex +$14 prem
Dec 9 2022
South Korea Grade A NA H2 Jan Hanwha +$16
TotalEnergies
South Korea Grade C NA H2 Jan Hanwha +$7
TotalEnergies
May 31 2022
Taiwan heavy 30KT July 11-20 Formosa mid $20 (30
days)
Taiwan NA 30KT July 11-20 Formosa mid $20 (30
days)
May 11 2022
South Korea hfrn 25KT H2 June GS Caltex +$1.50-$1.60
(30 days)
South Korea hfrn 25KT June 6-16 GS Caltex -$1-$2 (30
days)
March 23 2022
Japan min 73% 25KT H2 April Mitsui Chem NA
Aug 3 2021
Japan OSN NA H1 Oct Mitsui Chem -$3 (60 days)
S Korea hfrn NA H1 Sept Hanwha -$3
(Kavkaz)
July 28 2021
Japan min 78% NA H1 Sept Mitsui Chem +$16-$17
S Korea min 75% 75KT H1 Sept YNCC +$12
July 27 2021
S Korea min 75% NA H1 Sept Lotte +$13-$13.5
June 17 2021
Japan OSN 25KT H1 Aug Amec -$0.50 (60
days)
S Korea min 75% NA H2 Aug LG Chem ard +$4 (60
days)
June 15 2021
S Korea min 80% NA H2 July Lotte +$10
S Korea NA NA H2 July YNCC +$7.5
Malaysia NA NA H2 July Titan +$6
June 1 2021
S Korea hfrn NA H2 July GS Caltex +$11
S Korea min 75% NA H1 July (up LG Chem +$11-$12
to July 20) (Daesan)
S Korea min 75% NA H1 July (up LG Chem +$12-$13
to July 20) (Yeosu)
S Korea OSN NA H1 Aug LG Chem around parity
(60 days)
NOTE. All prices are on a delivered cif basis at a differential
to Japanese open-spec naphtha quotes unless otherwise noted.
(Reporting by Mohi Narayan; Editing by Rashmi Aich)
((Mohi.Narayan@thomsonreuters.com;))
Recent news on ASAHI KASEI
See all newsBrief: Asahi Kasei Corporation - Subsidiary To Launch Tender Offer For Shares Of Mori-Gumi
Table: ASAHI KASEI -6-MTH group results
Brief: Asahi Kasei Corporation - Announces Cancellation Of Treasury Shares
US FDA approves Asahi Kasei's drug for persistent herpes infections
Table: Asahi Kasei -Q1 group results